Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
Critical Reviews™ in Eukaryotic Gene Expression
Fator do impacto: 1.841 FI de cinco anos: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN Imprimir: 1045-4403
ISSN On-line: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.2017019467
pages 79-90

Acute HIV Infection: Advances in Mechanisms and Prophylactic Therapeutic Management

Muhammad Imran Qadir
Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, Bosan Road, Multan, Pakistan
Amman Abid
Faculty of Pharmacy, Bahauddin Zakariya University, Multan, Pakistan

RESUMO

Human infection by HIV is spreading rapidly. The spread of the virus is generally organized and transmission can be rectal, oral, or penile. Several types of cells are susceptible to viral invasion. The appearance of symptoms during infection can vary, but the presence of the virus can be confirmed by testing for the antigen p24. The ELISA test is used to detect viral p24 antigen and antiviral antibodies. This technique is approved for the purposes of clinical practice. Highly active antiretroviral therapy is usually a costly and lengthy treatment for HIV infection. A rapid point of care test has also been developed to detect acute infection. There is a need for preventing HIV infection and improving antiretroviral therapy. The treatment regime currently constitutes drugs that have the capability to concentrate in the genital tract of both males and females, as well as the use of integrase inhibitors that rapidly reduce viral load.


Articles with similar content:

Human Immunodeficiency Virus Type 1 Pharmacogenomics in Clinical Practice: Relevance of HIV-1 Drug Resistance Testing (Part 1)
Journal of Environmental Pathology, Toxicology and Oncology, Vol.22, 2003, issue 3
Nancy G. Klimas, Margaret Marchette, Charles Mitchell, Eduardo Meneses Sierra, Alejandro Isava, Dushyantha Jayaweera, Enriqueta Nunez, J. Brian Page, Gwendolyn Scott, Roberto Patarca, Nelson J. Rodriguez, Mary Ann Fletcher, Delia Rivera, Michael Kolber, Mirtha M. Sanabia, Rafael Campo, Cindy W. Mask, Jose Moreno, Michael Alter, Ricardo Vallejo, Catherine Boulanger
Human Immunodeficiency Virus Type 1 Pharmacogenomics in Clinical Practice: Relevance of HIV-1 Drug Resistance Testing (Part 2)
Journal of Environmental Pathology, Toxicology and Oncology, Vol.22, 2003, issue 4
Nancy G. Klimas, Margaret Marchette, Charles Mitchell, Eduardo Meneses Sierra, Alejandro Isava, Dushyantha Jayaweera, Enriqueta Nunez, J. Brian Page, Gwendolyn Scott, Roberto Patarca, Nelson J. Rodriguez, Mary Ann Fletcher, Delia Rivera, Michael Kolber, Mirtha M. Sanabia, Rafael Campo, Cindy W. Mask, Jose Moreno, Michael Alter, Ricardo Vallejo, Catherine Boulanger
Zika Virus: A Critical Analysis and Pharmaceutical Perspectives
Critical Reviews™ in Eukaryotic Gene Expression, Vol.28, 2018, issue 4
Muhammad Asif, Muhammad Sajid Hamid Akash, Shazia Anwer Bukhari, Zunaira Umar, Neelam Sultan, Irfan Ali
Psoriasis Clinical Implications and Treatment: A Review
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.30, 2013, issue 3
Ashlesha S. Raut, Vandana B. Patravale, Rashmi H. Prabhu
Revolutionary Advances in the Diagnosis and Treatment of Familial Adenomatous Polyposis
Journal of Environmental Pathology, Toxicology and Oncology, Vol.28, 2009, issue 1
William B. Long III, Richard Edlich, Margot E. Chase, Catherine L. Cross, Courtney A. Wack, K. Dean Gubler